期刊文献+

BAFF受体在人B淋巴瘤细胞中的作用研究

BAFF-R expression in B cell lymphoma
下载PDF
导出
摘要 目的测定B细胞活化因子(BAFF)受体在人B淋巴瘤细胞中的表达水平,探讨B细胞活化因子受体(BAFF-R)信号转导在人淋巴瘤细胞中的作用。方法选取3种人B淋巴瘤细胞系Raji、Daudi、BALL-1,通过流式细胞术、实时荧光定量聚合酶链反应(q RT-PCR)及Western blot检测BAFF的表达。结果流式细胞术结果显示,在3种人B淋巴瘤细胞系中均检出BAFF-R阳性表达,q RT-PCR和Western blot检测显示,在3种人B淋巴瘤细胞系中,BAFF-R基因与蛋白表达水平上调。结论人B淋巴瘤细胞系Raji、Daudi、BALL-1呈阳性表达,BAFF-R与B淋巴瘤细胞的生长、增殖关系密切。 Objective To detemine the expression of B-cell activating factor receptor(BAFF-R)in B celllymphoma and to explore the role of BAFF-R signal transduction in B cell lymphoma.Methods Human Bcelllymphoma cell lines Raji,Daudi and BALL-1were selected as the objects of study.BAFF-R expressionwas detected by flow cytometry,qRT-PCR and Western blot.Results Flow cytometry results demonstrated thatBAFF-R was up-regulated in all the three cell lines,qRT-PCR and Western-blot indicated the same results.Conclusions BAFF-R expression is up-regulated in all the three B-cell lymphoma cell lines,and closelycorrelated to the growth and proliferation of B-cell lymphoma.
作者 王永伦 封忠昕 葛晓军 Yong-lun Wang;Zhong-xin Feng;Xiao-jun Ge(Clinical Laboratory, the Affiliated Hospital of Zunyi Medical College,Zunyi, Guizhou 563003, China)
出处 《中国现代医学杂志》 CAS 北大核心 2017年第20期11-15,共5页 China Journal of Modern Medicine
基金 国家自然科学基金(No:81560487) 贵州省科学技术基金[No:黔科合J(2011)2264]
关键词 B细胞活化因子 B细胞活化因子受体 B淋巴瘤细胞 B-cell activating factor B-cell activating factor receptor B-cell lymphoma
  • 相关文献

参考文献5

二级参考文献53

  • 1杜建芳,王嘉玺,徐东刚.B细胞激活因子在免疫调节中的作用[J].中国实验血液学杂志,2006,14(3):631-634. 被引量:6
  • 2杨再兴,梁艳,朱烨,李畅,仲人前.可溶性肿瘤坏死因子相关凋亡诱导配体在强直性脊柱炎患者血清中的表达及临床意义[J].现代检验医学杂志,2007,22(2):92-94. 被引量:1
  • 3Wu KS, Hsiao CC, YU HR, et al. Helicobacter pylori infection and childhood idiopathic thrombocytopenic purpura [ J ]. Acta Paediatr Taiwan, 2007,48 ( 5 ) :263 - 266.
  • 4Cines DB, McMillan R. Pathogenesis of chronic immune thrombocytopenic purpura [ J ]. Curr Opln Hematol, 2007,14 ( 5 ) :511 - 514.
  • 5Zhang F, Chu X, Wang L, et al. Cell - mediated lysis of autologous platelets in chronic idiopathic thrombocytopenic purpura[J]. Eur J Haematol,2007,76 ( 5 ) :427 - 431.
  • 6Olsson B, Andersson PO, Jemas M, et al. T - cell - mediated cytotoxicity toward platelets in chronic idiopathic thrombocytopenic purpura [ J ]. Nat Med, 2007,93 ( 6 ) : 1123 - 1124.
  • 7Nardelli B, Belvedere O, Roschke V ,et al. Synthesis and release of B - lymphocyte stimulator from myeloid cells [ J 1. Blood, 2007,97 ( 2 ) : 198 -204.
  • 8Do RK, Hatada E, Lee H, et al. Attenuation of apoptosis underlies B lymphocyte stimulator enhancement of humoral immune response [ J ]. Exp Med ,2000,192 ( 7 ) :953 - 964.
  • 9Emmerich F, Bal G, Barakat A, et al. High -level serum B -cell activating factor and promoter polymorphisms in patients with idiopathic thrombocytopenic purpura [ J ]. Brit J Haematol, 2006,136 ( 7 ) : 309 - 314,.
  • 10Zhou Z,Chen Z,Li H,et al. BAFF and BAFF -R of peripheral blood and spleen mononuclear cells in idiopathic thrombocytopenic purpura [J]. Autoimmunity,2009,42(2 ) : 112 - 119.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部